Facial Manifestations of Pachydermoperiostosis Treated with Botulinum Toxin Type-A: Report of 3 Cases
Authors:
Open Access
- 1 June 2017
- journal article
- case report
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 97 (6) , 761-762
Abstract
Is missing (Short communication)...Keywords
This publication has 13 references indexed in Scilit:
- Primary Hypertrophic Osteoarthropathy: An Update on Patient Features and TreatmentThe Journal of Rheumatology, 2015
- Pathological characterization of pachydermia in pachydermoperiostosisThe Journal of Dermatology, 2015
- PachydermoperiostosisJournal of Craniofacial Surgery, 2014
- The novelSLCO2A1heterozygous missense mutation p.E427K and nonsense mutation p.R603* in a female patient with pachydermoperiostosis with an atypical phenotypeBritish Journal of Dermatology, 2014
- Pachydermoperiostosis – a case report of complete form and literature reviewJournal of Clinical Orthopaedics and Trauma, 2014
- Regulation of lipid production by acetylcholine signalling in human sebaceous glandsJournal of Dermatological Science, 2013
- Eyelid Thickening and Ptosis Associated with Pachydermoperiostosis: A Case Report and Review of LiteratureAesthetic Plastic Surgery, 2013
- Use of intradermal botulinum toxin to reduce sebum production and facial pore size.2008
- Pachydermoperiostosis: an updateClinical Genetics, 2005
- A Prospective, Double-Blind, Randomized, Parallel- Group, Dose-Ranging Study of Botulinum Toxin Type A in Female Subjects With Horizontal Forehead RhytidesDermatologic Surgery, 2003